Posted inCardiology Clinical Updates
Simplifying Access Site Closure in Transfemoral TAVR: Insights from the SINGLE-CLOSURE Trial
The SINGLE-CLOSURE trial demonstrated that single-ProGlide closure is noninferior to double-ProGlide closure in reducing vascular complications after transfemoral TAVR, offering a simpler alternative without increased risk.